Evaluation heparin binding protein as a prognostic biomarker for diagnosis of sepsis at tertiary care hospital, North India

Ashish Kumar Gupta; Rajendra Kumar Verma; Richa Giri; Ajesh Chandra Gupta; Shalini Gupta

doi:10.18203/2320-6012.ijrms20250679

Authors

Ashish Kumar Gupta Department of Medicine, GSVM Medical College, Kanpur, Uttar Pradesh, India
Rajendra Kumar Verma Department of Medicine, GSVM Medical College, Kanpur, Uttar Pradesh, India
Richa Giri Department of Medicine, GSVM Medical College, Kanpur, Uttar Pradesh, India
Ajesh Chandra Gupta Department of Medicine, GSVM Medical College, Kanpur, Uttar Pradesh, India
Shalini Gupta Department of Pathology, Dr. S. N. Medical College Jodhpur Rajasthan, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20250679

Keywords:

HPB, Biomarkers, Disease severity, Prognostic indicator, C-reactive protein, ICU, Infection, Mortality

Abstract

Background: Sepsis is a life-threatening condition marked by an uncontrolled inflammatory response to infection, leading to organ dysfunction and high mortality. In India, severe sepsis burdens ICU resources and impacts patient outcomes. This study aimed to evaluate heparin-binding protein (HBP) as a prognostic biomarker for assessing sepsis severity.

Methods: This prospective study was conducted at the department of medicine, G. S. V. M. medical college, Kanpur, from December 2022 to May 2024, including 113 adult patients suspected of sepsis or septic shock. Demographic data, HBP levels, and correlations with age, sex, disease severity, and other biomarkers C reactive protein (CRP and procalcitonin) were analyzed. Survival rates across different disease severities were also assessed.

Results: The mean age of participants was 53.2±19.3 years. Baseline HBP levels were significantly higher in infection cases compared to non-infection cases (11.21±5.51 ng/ml vs. 4.31±3.72 ng/ml, p<0.001). HBP levels decreased significantly over 72 hours but remained elevated in non-survivors (9.81±6.25 ng/ml vs. 7.17±5.18 ng/ml, p=0.001). HBP was more effective than CRP and procalcitonin in predicting infection severity and outcomes.

Conclusions: HBP is a promising biomarker for assessing sepsis severity and predicting survival. Elevated HBP levels correlate with increased infection severity and mortality. HBP offers an advantage in early diagnosis and prognosis, and further research is needed to optimize its use in sepsis management.

Metrics

Metrics Loading ...

References

Sepsis Alliance. Sepsis Overview. 2024. Available at: https://www.sepsis.org/. Accessed on 12 December 2024.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. DOI: https://doi.org/10.1001/jama.2016.0287

Jain S, Kumar A, Agarwal S. Indian Intensive Care Case Mix and Practice Patterns Study (INDICAPS): A report on the prevalence of severe sepsis and septic shock in Indian ICUs. Indian J Crit Care Med. 2014;18(10):575-84.

Khanna A, Mehta Y, Reddy B. The epidemiology of sepsis in Indian ICUs: A single centre experience. Indian J Crit Care Med. 2018;22(3):196-201.

Van der Poll T, Van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nature Rev Immunol. 2017;17(7):407-20. DOI: https://doi.org/10.1038/nri.2017.36

Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock. JAMA. 2016;315(8):775-87. DOI: https://doi.org/10.1001/jama.2016.0289

Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 Update. Crit Care Med. 2018;46(6):997-1000. DOI: https://doi.org/10.1097/CCM.0000000000003119

Jones AE, Kline JA, Trzeciak S. The score from the Sequential Organ Failure Assessment for forecasting the course of patients who present to the emergency room with evidence of hypoperfusion and severe sepsis. Crit Care Med. 2009;37(5):1649-54. DOI: https://doi.org/10.1097/CCM.0b013e31819def97

Hotchkiss RS, Moldawer LL, Opal SM, Jean-Louis V, Turnbull IR, Reinhart K. Septic shock and sepsis Nat Rev Dis Primers. 2016;2:16045. DOI: https://doi.org/10.1038/nrdp.2016.45

Fisher J, Linder A. Heparin-binding protein: a key player in the pathogenesis of organ dysfunction in sepsis is heparin-binding protein. J Internal Med. 2017;281(6):562-74. DOI: https://doi.org/10.1111/joim.12604

Kahn F. Characteristics of sepsis patients in the emergency department. J Emerg Med. 2018;53(4):718.

Zuo L, Li X, Wang L, Yuan H, Liao Z, Zhou S, et al. Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China. BMJ Open. 2024;14(6):e078687. DOI: https://doi.org/10.1136/bmjopen-2023-078687